Cited by 5Autism Spectrum Disorder ResearchBehavioral and Psychological StudiesChild Nutrition and Feeding Issues

Research-Based Intervention (RBI) for Autism Spectrum Disorder: Looking beyond Traditional Models and Outcome Measures for Clinical Trials

Open access
Narzisi, Antonio, Alonso-Esteban, Yurena, Masi, Gabriele, Alcantud-Marín, Francisco·2022·Children

Abstract

The rising prevalence of Autism Spectrum Disorders (ASD) has led to a quickly increasing need for effective interventions. Several criteria and measures have been developed to critically assess these interventions with particular focus on the evaluation of the efficacy. Given the huge diversity of ASD symptoms and the different levels of severity across individuals, identifying a one size fits all intervention approach is challenging, and the question What works and for whom? Remains still unanswered. Why do we seem to be dragging our feet on this fundamental issue? The main aim of this paper is to answer this question through four non-alternative points. First, there are a scarce number of studies with a solid methodology. Secondly, most trials on intervention efficacy for ASD are designed exclusively in terms of behavioral outcomes. Thirdly, there is a reduced use of biologically oriented outcome measures. Fourthly, in most clinical trials, appropriate practices emerging from research evidence are not systematically applied. A strong effort to improve the methodology of clinical trials is mandatory for the future of autism research. The development of a research-based intervention (RBI) perspective aimed at better integrating: (a) evidence-based approaches; (b) more sensitive behavioral outcome measures; and (c) biomarkers, with the aim of increasing a more detailed clustering of phenotypes, may strongly improve our approach to a precision medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/children9030430

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The development of sensitive behavioral measures, along with specialized biomarkers, will allow a better understanding of the specific factors contributing to anxiety in ASD and can help research on the causes of concurrent anxiety in autistic people and provide targets for improving intervention.

    “El desarrollo de medidas conductuales sensibles, junto con algunos biomarcadores especializados (Narzisi et al., 2022), permitirá una mejor comprensión de los factores específicos que contribuyen a la ansiedad en el TEA y puede ayudar a la investigación sobre las causas de la ansiedad concurrente en personas autistas y también proporcionar objetivos para mejorar la intervención (South y Rodgers, 2”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. [2]Francis K. Karantanos G. Al-Ozairi A. AlKhadhari S. Prevention in Autism Spectrum Disorder: A Lifelong Focused Approach Brain Sci. 2021 11 151 10.3390/brainsci11020151 33498888 PMC7911370 · DOI
  2. [3]Green V. Pituch K. Itchon J. Choi A. O’Reilly M. Sigafoos J. Internet survey of treatments used by parents of children with autism Res. Dev. Disabil. 2006 27 70 84 10.1016/j.ridd.2004.12.002 15919178 · DOI · Paper page
  3. [4]Narzisi A. Colombi C. Balottin U. Muratori F. Non-pharmacological treatments in autism spectrum disorders: An overview on early interventions for pre-schoolers Curr. Clin. Pharmacol. 2014 9 17 26 10.2174/15748847113086660071 24050743 · DOI
  4. [5]Cook B. Buysse V. Klingner J. CEC’s standards for classifying the evidence base of practices in special education Remedial Spec. Educ. 2014 36 220 234 10.1177/0741932514557271 · DOI
  5. [6]Harris R. Helfand M. Woolf S. Lohr K. Mulrow C. Teutsch S. Atkins D. Current methods of the US Preventive Services Task Force: A review of the process Am. J. Prev. Med. 2001 20 21 35 10.1016/S0749-3797(01)00261-6 11306229 · DOI
  6. [7]Kemdall T. Megnin-Viggars O. Gould N. Taylor C. Burt L. Baird G. Management of autism in children and young people: Summary of NICE and SCIE guidance Br. Med. J. 2013 347 f4865 10.1136/bmj.f4865 23985309 · DOI
  7. [8]Manglione M. Gans D. Das L. Timbie J. Kasari C. Technical Expert Panel, & HRSA AIRB Network Nonmedical Interventions for Children With ASD: Recommended Guidelines and Further Research Needs Pediatrics 2012 130 S169 10.1542/peds.2012-0900O 23118248 · DOI
  8. [9]Reichow B. Hume K. Barton E. Boyd B. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD) Cochrane Database Syst. Rev. 2018 5 1 16 10.1002/14651858.CD009260.pub3 PMC6494600 29742275 · DOI · Paper page
  9. [10]Simith T. Iadarola S. Evidence base update for autism spectrum disorder J. Clin. Child Adolesc. Psychol. 2015 44 897 922 10.1080/15374416.2015.1077448 26430947 · DOI · Paper page
  10. [12]Green J. Charman T. McConachie H. Aldred C. Slonims V. Howlin P. Le Couteur A. Leadbitter K. Hudry K. Byford S. Parent-mediated communication-focused treatment in children with autism (PACT): A randomised controlled trial Lancet 2010 375 2152 2160 10.1016/S0140-6736(10)60587-9 20494434 PMC2890859 · DOI · Paper page
  11. [13]Landa R. Efficacy of early interventions for infants and young children with, and at risk for, autism spectrum disorders Int. Rev. Psychiatry 2018 30 25 39 10.1080/09540261.2018.1432574 29537331 PMC6034700 · DOI
  12. [14]Nahmias A. Pellecchia M. Stahmer A. Mandell D. Effectiveness of community-based early intervention for children with autism spectrum disorder: A meta-analysis J. Child Psychol. Psychiatry 2019 60 1200 1209 10.1111/jcpp.13073 31206690 · DOI · Paper page
  13. [15]Vivanti G. Stahmer A. Early intervention for autism: Are we prioritizing feasibility at the expense of effectiveness? A cautionary note Autism 2018 22 770 773 10.1177/1362361318803043 30235939 · DOI
  14. [16]French L. Kennedy E. Annual Research Review: Early intervention for infants and young children with, or at-risk of, autism spectrum disorder: A systematic review J. Child Psychol. Psychiatry 2018 59 444 456 10.1111/jcpp.12828 29052838 · DOI
  15. [17]Schreibman L. Dawson G. Stahmer A.C. Landa R. Rogers S.J. McGee G.G. Kasari C. Ingersoll B. Kaiser A.P. Bruinsma Y. Naturalistic Developmental Behavioral Interventions: Empirically Validated Treatments for Autism Spectrum Disorder J. Autism Dev. Disord. 2015 45 2411 2428 10.1007/s10803-015-2407-8 25737021 PMC4513196 · DOI · Paper page
  16. [18]Curruthers S. Charman T. El Hawi N. Ah Kim Y. Randle R. Lord C. PACT Consortium Utility of the Autism Diagnostic Observation Schedule and the Brief Observation of Social and Communication Change for Measuring Outcomes for a Parent-Mediated Early Autism Intervention Autism Res. 2021 14 411 425 10.1002/aur.2449 33274842 PMC7898818 · DOI
  17. [19]Grzadzinski R. Carr T. Colombi C. McGuire K. Dufek S. Pickles A. Lord C. Measuring Changes in Social Communication Behaviors: Preliminary Development of the Brief Observation of Social Communication Change (BOSCC) J. Autism Dev. Disord. 2016 46 264 2479 10.1007/s10803-016-2782-9 27062034 · DOI
  18. [20]Green J. Aldred C. Charman T. Le Couteur A. Emsley R.A. Grahame V. Howlin P. Humphrey N. Leadbitter K. McConachie H. Paediatric Autism Communication Therapy-Generalised (PACT-G) against treatment as usual for reducing symptom severity in young children with autism spectrum disorder: Study protocol for a randomised controlled trial Trials 2018 19 514 10.1186/s13063-018-2881-3 30241574 PMC6150959 · DOI
  19. [21]McClure L.A. Lee N.L. Sand K. Vivanti G. Fein D. Stahmer A. Robins D.L. Connecting the Dots: A cluster-randomized clinical trial integrating standardized autism spectrum disorders screening, high-quality treatment, and long-term outcomes Trials 2021 22 319 33934719 PMC8091523
  20. [22]Kim S. Grzadzinski R. Martinez K. Lord C. Measuring treatment response in children with autism spectrum disorder: Applications of the Brief Observation of Social Communication Change to the Autism Diagnostic Observation Schedule Autism 2019 23 1176 1185 10.1177/1362361318793253 30303398 PMC6522321 · DOI
  21. [24]Green J. Garg S. Annual Research Review: The state of autism intervention science: Progress, target psychological and biological mechanisms and future prospects J. Child Psychol. Psychiatry 2018 59 424 443 10.1111/jcpp.12892 29574740 · DOI
  22. [26]Aldred C. Green J. Adams C. A new social communication intervention for children with autism: Pilot randomised controlled treatment study suggesting effectiveness J. Child Psychol. Psychiatry 2004 45 1420 1430 10.1111/j.1469-7610.2004.00338.x 15482502 · DOI · Paper page
  23. [27]Aldred C. Green J. Emsley R. McConachie M. Brief report: Mediation of treatment effect in a communication intervention for pre-school children with autism J. Autism Dev. Disord. 2011 42 447 454 10.1007/s10803-011-1248-3 21512834 · DOI
  24. [28]Oono I.P. Honey E.J. McConachie H. Parent-mediated early intervention for young children with autism spectrum disorders (ASD) Cochrane Database Syst. Rev. 2013 30 CD009774 PMC11831248 23633377
  25. [30]Wang Y. Wang P. Xu X. Godstein J. McConkie A. Cheung S. Jiang Y. Genetics of Autism Spectrum Disorders: The Opportunity and Challenge in the Genetics Clinic The Molecular Basis of Autism Fantemi H. Springer New York, NY, USA 2015 33 66
  26. [31]Muglia P. Filosi M. Da Ros L. Kam-Thong T. Nardocci F. Trabetti E. Ratti E. Rizzini P. Zuddas A. Bernardina B.D. The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations BMC Psychiatry 2018 18 369 10.1186/s12888-018-1937-y 30463616 PMC6247619 · DOI
  27. [33]Bradshaw J. Shic F. Holden A. Horowitz E. Barrett A. German T. Vernon T. The Use of Eye Tracking as a Biomarker of Treatment Outcome in a Pilot Randomized Clinical Trial for Young Children with Autism Autism Res. 2019 12 779 793 10.1002/aur.2093 30891960 · DOI
  28. [34]Mastergeorge A.M. Kahathuduwa C. Blume J. Eye-Tracking in Infants and Young Children at Risk for Autism Spectrum Disorder: A Systematic Review of Visual Stimuli in Experimental Paradigms J. Autism Dev. Disord. 2021 51 2578 2599 10.1007/s10803-020-04731-w 33011860 · DOI
  29. [35]Nyström P. Thorup E. Bölte S. Falck-Ytter T. Joint Attention in Infancy and the Emergence of Autism Biol. Psychiatry 2019 86 631 638 10.1016/j.biopsych.2019.05.006 31262432 · DOI
  30. [36]Billeci L. Narzisi A. Campatelli G. Crifaci G. Calderoni S. Gagliano A. Calzone C. Colombi C. Pioggia G. Muratori F. Disentangling the initiation from the response in joint attention: An eye-tracking study in toddlers with autism spectrum disorders Transl. Psychiatry 2016 6 e808 10.1038/tp.2016.75 27187230 PMC5070062 · DOI
  31. [37]Muratori F. Billeci L. Calderoni S. Boncoddo M. Lattarulo C. Costanzo V. Turi M. Colombi C. Narzisi A. How Attention to Faces and Objects Changes Over Time in Toddlers with Autism Spectrum Disorders: Preliminary Evidence from An Eye Tracking Study Brain Sci. 2019 9 344 10.3390/brainsci9120344 PMC6955945 31783561 · DOI
  32. [38]Pierce K. Marinero S. Hazin R. McKenna B. Barnes C.C. Malige A. Eye Tracking Reveals Abnormal Visual Preference for Geometric Images as an Early Biomarker of an Autism Spectrum Disorder Subtype Associated with Increased Symptom Severity Biol. Psychiatry 2016 79 657 666 10.1016/j.biopsych.2015.03.032 25981170 PMC4600640 · DOI
  33. [39]Murias M. Major S. Davlantis K. Franz L. Harris A. Rardin B. Sabatos-DeVito M. Dawson G. Validation of eye-tracking measures of social attention as a potential biomarker for autism clinical trials Autism Res. 2018 11 166 174 10.1002/aur.1894 29193826 · DOI
  34. [40]Crehan E.T. Althoff R.R. Me looking at you, looking at me: The stare-in-the-crowd effect and autism spectrum disorder J. Psychiatr. Res. 2021 140 101 109 10.1016/j.jpsychires.2021.05.050 34102517 · DOI
  35. [41]Wang Y. Peng S. Shao Z. Feng T. Active Viewing Facilitates Gaze to the Eye Region in Young Children with Autism Spectrum Disorder J. Autism Dev. Disord. 2022 7 10.1007/s10803-022-05462-w 35129796 · DOI
  36. [42]Barone R. Spampinato C. Pino C. Palermo F. Scuderi A. Zavattieri A. Gulisano M. Giordano D. Rizzo R. Online comprehension across different semantic categories in preschool children with autism spectrum disorder PLoS ONE 2019 14 e0211802 10.1371/journal.pone.0211802 30742652 PMC6370186 · DOI
  37. [43]Stevenson R.A. Philipp-Muller A. Hazlett N. Wang Z.Y. Luk J. Lee J. Black K.R. Yeung L.K. Shafai F. Segers M. Conjunctive Visual Processing Appears Abnormal in Autism Front. Psychol. 2019 9 2668 10.3389/fpsyg.2018.02668 30713514 PMC6346680 · DOI
  38. [44]Shou G. Mosconi M.W. Wang J. Ethridge L.E. Sweeney J.A. Ding L. Electrophysiological signatures of atypical intrinsic brain connectivity networks in autism J. Neural Eng. 2017 14 046010 10.1088/1741-2552/aa6b6b 28540866 PMC5737951 · DOI
  39. [45]Gomot M. Blanc R. Clery H. Roux S. Barthelemy C. Bruneau N. Candidate Electrophysiological Endophenotypes of Hyper-Reactivity to Change in Autism J. Autism Dev. Disord. 2011 41 705 714 10.1007/s10803-010-1091-y 20827502 · DOI
  40. [46]Pagani M. Barsotti N. Bertero A. Trakoshis S. Ulysse L. Locarno A. Miseviciute I. De Felice A. Canella C. Supekar K. mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity Nat. Commun. 2021 12 6084 10.1038/s41467-021-26131-z 34667149 PMC8526836 · DOI
  41. [47]Zerbi V. Pagani M. Markicevic M. Matteoli M. Pozzi D. Fagiolini M. Bozzi Y. Galbusera A. Scattoni M.L. Provenzano G. Brain mapping across 16 autism mouse models reveals a spectrum of functional connectivity subtypes Mol. Psychiatry 2021 26 7610 7620 10.1038/s41380-021-01245-4 34381171 PMC8873017 · DOI · Paper page
  42. [48]Yang D. Beam D. Pelphrey K. Abdullahi S. Jou R. Cortical morphological markers in children with autism: A structural magnetic resonance imaging study of thickness, area, volume, and gyrification Mol. Autism 2016 7 11 10.1186/s13229-016-0076-x 26816612 PMC4727390 · DOI
  43. [49]Zwaigenbaum L. Bauman M.L. Choueiri R. Kasari C. Carter A. Granpeesheh D. Mailloux Z. Smith Roley S. Wagner S. Fein D. Early Intervention for Children with Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research Pediatrics 2015 136 (Suppl. 1) S60 S81 10.1542/peds.2014-3667E 26430170 PMC9923898 · DOI · Paper page
  44. [50]Klein C.B. Swain D.M. Vibert B. Clark-Whitney E. Lemelman A.R. Giordano J.A. Winter J. Kim S.H. Implementation of Video Feedback Within a Community Based Naturalistic Developmental Behavioral Intervention Program for Toddlers with ASD: Pilot Study Front. Psychiatry 2021 12 763367 10.3389/fpsyt.2021.763367 34925094 PMC8674462 · DOI
  45. [51]Whitehouse A.J. Varcin K.J. Alvares G.A. Barbaro J. Bent C. Boutrus M. Chetcuti L. Cooper M.N. Clark A. Davidson E. Pre-emptive intervention versus treatment as usual for infants showing early behavioural risk signs of autism spectrum disorder: A single-blind, randomised controlled trial Lancet Child Adolesc. Health 2019 3 605 615 10.1016/S2352-4642(19)30184-1 31324597 · DOI
  46. [52]Poslawsky I.E. Naber F.B. Bakermans-Kranenburg M.J. Van Daalen E. Van Engeland H. Van Ijzendoorn M.H. Video-feedback Intervention to promote Positive Parenting adapted to Autism (VIPP-AUTI): A randomized controlled trial Autism 2015 19 588 603 10.1177/1362361314537124 24919961 · DOI
  47. [53]Hong M.P. Erickson C.A. Investigational drugs in early-stage clinical trials for autism spectrum disorder Expert Opin. Investig. Drugs 2019 28 709 718 10.1080/13543784.2019.1649656 31352835 · DOI
  48. [54]Ruggeri B. Sarkans U. Schumann G. Persico A. Biomarkers in autism spectrum disorder: The old and the new Psychopharmacology 2014 231 1201 1216 10.1007/s00213-013-3290-7 24096533 · DOI

Cited by

Sorted by citations

Authors
Narzisi, A., Alonso-Esteban, Y., Masi, G., & Alcantud-Marín, F.
Affiliations
  • Fondazione Stella Maris (IT)
  • Universitat de València (ES)
  • Department of Developmental and Educational Psychology, University of Valencia, Avenida de Blasco Ibáñez, 13, 46010 Valencia, Spain
Corresponding author
Narzisi, Antonio
Venue
Children
Publisher
MDPI AG
Published
2022-03-18
Volume
9
Issue
3
Pages
430
ISSN
2227-9067 (ISSN-L)
OpenAlex
W4220896671
Cited by
5
References
6
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1
FWCI
0.64
Type
journal article
Language
en
Open access
Locations
  • Children (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
autism spectrum disorder, research-based interventions, intervention efficacy, clinical trial design, biomarkers, precision medicine, autism phenotype, evidence-based practice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review